- Corporate Officers - T
- Thulin Inge G
Insider Trading History of Thulin Inge G
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Thulin Inge G since 2005.
This trader's CIK number is 1263739.
At the time of last reporting, Thulin Inge G was the Director of Merck & Co., Inc.. (stock ticker symbol MRK).
Also see all insider trading activities at Merck & Co., Inc..
Note that in the past
THULIN INGE G also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Chevron Corp (CVX) by Thulin Inge G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | CVX | 487 | $50,096 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at 3m Co (MMM) by Thulin Inge G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | MMM | 0 | $0 | 53,578 | $10,937,878 | 50,166 | $3,949,065 |
| 2018 | MMM | 0 | $0 | 59,584 | $14,987,843 | 59,584 | $3,224,090 |
| 2017 | MMM | 0 | $0 | 57,615 | $10,603,707 | 50,792 | $3,920,126 |
| 2016 | MMM | 0 | $0 | 45,758 | $7,780,498 | 45,758 | $3,879,363 |
| 2015 | MMM | 0 | $0 | 52,000 | $8,104,304 | 52,000 | $4,542,200 |
| 2014 | MMM | 0 | $0 | 119,611 | $16,639,834 | 111,676 | $10,695,649 |
| 2013 | MMM | 0 | $0 | 5,614 | $702,844 | 86,686 | $7,583,895 |
| 2012 | MMM | 0 | $0 | 0 | $0 | 56,130 | $4,582,289 |
| 2011 | MMM | 0 | $0 | 11,858 | $1,140,277 | 63,056 | $4,219,057 |
| 2010 | MMM | 0 | $0 | 7,500 | $636,630 | 28,817 | $1,808,433 |
| 2009 | MMM | 0 | $0 | 0 | $0 | 10,560 | $457,776 |
| 2008 | MMM | 0 | $0 | 0 | $0 | 5,280 | $250,800 |
| 2005 | MMM | 1,000 | $74,200 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Merck & Co., Inc. (MRK) by Thulin Inge G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | MRK | 2,832 | $249,924 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Thulin Inge G:
1. Chevron Corp (CVX)
2. 3m Co (MMM)
3. Merck & Co., Inc. (MRK)
Table 1. Insider trading of Chevron Corp (CVX) by Thulin Inge G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-08-15 | CVX | Buy | 487 | 102.87 | 50,096 |
Table 2. Insider trading of 3m Co (MMM) by Thulin Inge G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-03-29 | MMM | Sale | 8,215 | 208.06 | 1,709,253 |
| 2019-03-29 | MMM | Sale | 5,863 | 208.15 | 1,220,395 |
| 2019-03-29 | MMM | Option Ex | 25,083 | 78.72 | 1,974,533 |
| 2019-03-29 | MMM | Sale | 6,034 | 208.28 | 1,256,731 |
| 2019-03-29 | MMM | Sale | 5,485 | 208.58 | 1,144,066 |
| 2019-03-29 | MMM | Sale | 1,192 | 208.92 | 249,033 |
| 2019-01-31 | MMM | Sale | 13,290 | 200.03 | 2,658,385 |
| 2019-01-31 | MMM | Option Ex | 13,290 | 78.72 | 1,046,188 |
| 2019-01-30 | MMM | Option Ex | 11,793 | 78.72 | 928,344 |
| 2019-01-30 | MMM | Sale | 13,499 | 200.02 | 2,700,015 |
| 2018-01-31 | MMM | Sale | 35,236 | 251.34 | 8,856,251 |
| 2018-01-31 | MMM | Option Ex | 59,584 | 54.11 | 3,224,090 |
| 2018-01-31 | MMM | Sale | 18,866 | 251.75 | 4,749,534 |
| 2018-01-31 | MMM | Sale | 5,438 | 252.11 | 1,370,957 |
| 2018-01-31 | MMM | Sale | 44 | 252.31 | 11,101 |
| 2017-10-27 | MMM | Sale | 6,823 | 233.15 | 1,590,755 |
| 2017-02-09 | MMM | Option Ex | 50,792 | 77.18 | 3,920,126 |
| 2017-02-09 | MMM | Sale | 14,680 | 177.27 | 2,602,279 |
| 2017-02-09 | MMM | Sale | 28,183 | 177.49 | 5,002,285 |
| 2017-02-09 | MMM | Sale | 7,929 | 177.62 | 1,408,388 |
| 2016-05-11 | MMM | Sale | 13,947 | 169.92 | 2,369,846 |
| 2016-05-11 | MMM | Option Ex | 45,758 | 84.78 | 3,879,363 |
| 2016-05-11 | MMM | Sale | 5,658 | 170.22 | 963,099 |
| 2016-05-11 | MMM | Sale | 26,153 | 170.06 | 4,447,553 |
| 2015-10-27 | MMM | Sale | 52,000 | 155.85 | 8,104,304 |
| 2015-10-27 | MMM | Option Ex | 52,000 | 87.35 | 4,542,200 |
| 2014-08-05 | MMM | Sale | 25,645 | 139.83 | 3,586,042 |
| 2014-08-05 | MMM | Sale | 28,581 | 139.68 | 3,992,079 |
| 2014-08-05 | MMM | Sale | 13,749 | 139.47 | 1,917,518 |
| 2014-08-05 | MMM | Option Ex | 67,975 | 76.80 | 5,220,480 |
| 2014-05-06 | MMM | Option Ex | 43,677 | 125.28 | 5,471,854 |
| 2014-05-06 | MMM | Sale | 9,331 | 139.37 | 1,300,452 |
| 2014-05-06 | MMM | Sale | 10,300 | 139.73 | 1,439,239 |
| 2014-05-06 | MMM | Sale | 16,309 | 139.56 | 2,276,084 |
| 2014-05-06 | MMM | Sale | 400 | 140.19 | 56,076 |
| 2014-05-06 | MMM | Sale | 7,337 | 139.95 | 1,026,842 |
| 2014-02-19 | MMM | Sale | 7,959 | 131.36 | 1,045,502 |
| 2014-01-02 | MMM | Option Ex | 24 | 138.13 | 3,315 |
| 2013-10-29 | MMM | Sale | 5,614 | 125.19 | 702,844 |
| 2013-10-29 | MMM | Option Ex | 56,114 | 84.40 | 4,736,021 |
| 2013-05-03 | MMM | Option Ex | 27,278 | 92.00 | 2,509,712 |
| 2013-02-08 | MMM | Option Ex | 3,294 | 102.66 | 338,162 |
| 2012-03-02 | MMM | Option Ex | 25,481 | 87.52 | 2,230,097 |
| 2012-02-21 | MMM | Option Ex | 14,691 | 64.50 | 947,569 |
| 2012-02-09 | MMM | Option Ex | 15,958 | 88.02 | 1,404,623 |
| 2011-11-04 | MMM | Option Ex | 16,794 | 64.50 | 1,083,213 |
| 2011-05-04 | MMM | Sale | 11,858 | 96.16 | 1,140,277 |
| 2011-04-29 | MMM | Option Ex | 30,146 | 63.17 | 1,904,473 |
| 2011-03-18 | MMM | Option Ex | 1 | 89.50 | 89 |
| 2011-02-14 | MMM | Option Ex | 12,821 | 72.71 | 932,253 |
| 2011-02-09 | MMM | Option Ex | 3,294 | 90.78 | 299,029 |
| 2010-07-30 | MMM | Sale | 7,500 | 84.88 | 636,630 |
| 2010-07-27 | MMM | Option Ex | 22,465 | 60.24 | 1,353,224 |
| 2010-02-17 | MMM | Option Ex | 279 | 78.72 | 21,962 |
| 2010-02-11 | MMM | Option Ex | 6,073 | 71.34 | 433,247 |
| 2009-08-11 | MMM | Option Ex | 10,560 | 43.35 | 457,776 |
| 2008-03-13 | MMM | Option Ex | 5,280 | 47.50 | 250,800 |
| 2005-07-25 | MMM | Buy | 1,000 | 74.20 | 74,200 |
Table 3. Insider trading of Merck & Co., Inc. (MRK) by Thulin Inge G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-06 | MRK | Buy | 2,832 | 88.25 | 249,924 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Thulin Inge G
(Director of Merck & Co., Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.